ARTICLE | Clinical News
Procysteine small molecule prodrug to replenish glutathione: Began Phase II dose-ranging trial to find the optimal dose, and to establish the relationship betwe
October 2, 1995 7:00 AM UTC
Transcend Therapeutics Inc., Cambridge, Mass. Product: Procysteine small molecule prodrug to replenish glutathione, an antioxidant Indication: Multiple organ dysfunction due to sepsis Status: Began Ph...